15. jan. 2025 ... Teva Pharmaceuticals USA Inc. is taking the Biden administration to court over its drug price negotiation program, days before the US government is set to ...
21. juni 2024 ... Teva Pharmaceuticals filed a request with the First Circuit Court of Appeals seeking to hold in abeyance its interlocutory appeal concerning the US Department ...
25. juni 2024 ... ... Teva's 2024 financial outlook, which the Company reaffirms. Teva is an Israeli. ... Litigation for the Company's Taxable Years 2008-2020. June 25, ...
Frosh today announced a multistate lawsuit against Teva Pharmaceuticals and 19 of the nation's largest generic drug manufacturers, alleging a broad ...
3. nov. 2022 ... Teva will pay up to $4.247 billion nationwide to settle opioid claims as part of the Teva Global Settlement. New York's share of that amount is ...
Alkermes Announces Settlement With Teva Related to VIVITROL® Patent Litigation · the United States prior to the expiration of Alkermes' · U.S. Patent No.
26. juli 2022 ... Teva in 2019 proposed to settle its nationwide opioid liability for $250 million in cash and $23 billion in contributed medicines that was ...
15. jan. 2025 ... Teva. Pharmaceuticals USA, Inc. sells AUSTEDO and AUSTEDO XR and will sell the product de- scribed in Teva's applications for generic ...
30. apr. 2024 ... Teva Beats $200 Million Lawsuit Over Pharmaceutical Acquisition ... Teva Pharmaceutical Industries Ltd.'s US unit prevailed in court Tuesday ...
8. jan. 2025 ... This Agreement resolves the patent litigation brought by Catalyst and SERB in response to Teva's Abbreviated New Drug Application (ANDA) seeking approval to ...